4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001873392-26-000002
President & COO sold 15,010 shares at an average $13.04 ($195,771)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dowden Nathan J President & COO | 2026-03-09 | Sale 10b5-1 | −3,116 | $13.02 | $40,583 | 210,482 | D |
| Dowden Nathan J President & COO | 2026-03-10 | Sale 10b5-1 | −11,894 | $13.05 | $155,188 | 198,588 | D |
| Open-market sales · 15,010 sh · avg $13.04 · $195,771 | |||||||
Loading xslF345X05/wk-form4_1773261310.xml…